324 related articles for article (PubMed ID: 11197285)
1. Risk factors for erosive reflux esophagitis: a case-control study.
Avidan B; Sonnenberg A; Schnell TG; Sontag SJ
Am J Gastroenterol; 2001 Jan; 96(1):41-6. PubMed ID: 11197285
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of reflux oesophagitis among upper endoscopies of Iranian patients.
Rezailashkajani M; Roshandel D; Shafaee S; Zali MR
Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):499-506. PubMed ID: 17489061
[TBL] [Abstract][Full Text] [Related]
3. Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan.
Fujiwara Y; Higuchi K; Shiba M; Yamamori K; Watanabe Y; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Arakawa T
Am J Gastroenterol; 2005 Apr; 100(4):754-8. PubMed ID: 15784015
[TBL] [Abstract][Full Text] [Related]
4. Association of esophagitis and esophageal strictures with diseases treated with nonsteroidal anti-inflammatory drugs.
El-Serag HB; Sonnenberg A
Am J Gastroenterol; 1997 Jan; 92(1):52-6. PubMed ID: 8995937
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative.
Labenz J; Jaspersen D; Kulig M; Leodolter A; Lind T; Meyer-Sabellek W; Stolte M; Vieth M; Willich S; Malfertheiner P
Am J Gastroenterol; 2004 Sep; 99(9):1652-6. PubMed ID: 15330897
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of reflux esophagitis in older people: a study of 840 consecutive patients.
Pilotto A; Franceschi M; Leandro G; Scarcelli C; D'Ambrosio LP; Seripa D; Perri F; Niro V; Paris F; Andriulli A; Di Mario F
J Am Geriatr Soc; 2006 Oct; 54(10):1537-42. PubMed ID: 17038071
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors influencing healing of reflux esophagitis. A controlled trial of omeprazole versus ranitidine. Study group Omega].
Barbier JP; Haccoun P; Bergmann JF; Arnould B; Hamelin B
Ann Gastroenterol Hepatol (Paris); 1993; 29(4):213-8. PubMed ID: 8239492
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.
Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ
Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456
[TBL] [Abstract][Full Text] [Related]
9. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption.
Kaufman DW; Kelly JP; Wiholm BE; Laszlo A; Sheehan JE; Koff RS; Shapiro S
Am J Gastroenterol; 1999 Nov; 94(11):3189-96. PubMed ID: 10566713
[TBL] [Abstract][Full Text] [Related]
10. Bleeding reflux esophagitis: a prospective 1-year study in a university hospital.
Costa ND; Cadiot G; Merle C; Jolly D; Bouche O; Thiéfin G; Zeitoun P
Am J Gastroenterol; 2001 Jan; 96(1):47-51. PubMed ID: 11197286
[TBL] [Abstract][Full Text] [Related]
11. Increased body mass index after H. pylori eradication for duodenal ulcer predisposes to erosive reflux esophagitis.
Yang YJ; Sheu BS; Chang WL; Cheng HC; Yang HB
J Clin Gastroenterol; 2009 Sep; 43(8):705-10. PubMed ID: 19398924
[TBL] [Abstract][Full Text] [Related]
12. Male sex, hiatus hernia, and Helicobacter pylori infection associated with asymptomatic erosive esophagitis.
Wang PC; Hsu CS; Tseng TC; Hsieh TC; Chen CH; Su WC; Lin HH; Wang CC
J Gastroenterol Hepatol; 2012 Mar; 27(3):586-91. PubMed ID: 21871022
[TBL] [Abstract][Full Text] [Related]
13. Relevance of ineffective esophageal motility and hyperactive acid sensitization in patients with gastroesophageal reflux.
Hong SJ; Ko BM; Jung IS; Ryu CB; Moon JH; Cho JY; Kim JO; Lee JS; Lee MS; Shim CS; Kim BS
J Gastroenterol Hepatol; 2007 Oct; 22(10):1662-5. PubMed ID: 17559356
[TBL] [Abstract][Full Text] [Related]
14. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Anderson LA; Cantwell MM; Watson RG; Johnston BT; Murphy SJ; Ferguson HR; McGuigan J; Comber H; Reynolds JV; Murray LJ
Gastroenterology; 2009 Mar; 136(3):799-805. PubMed ID: 19162028
[TBL] [Abstract][Full Text] [Related]
15. No association between gallstones and gastroesophageal reflux disease.
Avidan B; Sonnenberg A; Schnell TG; Sontag SJ
Am J Gastroenterol; 2001 Oct; 96(10):2858-62. PubMed ID: 11693317
[TBL] [Abstract][Full Text] [Related]
16. Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease.
Jones MP; Sloan SS; Rabine JC; Ebert CC; Huang CF; Kahrilas PJ
Am J Gastroenterol; 2001 Jun; 96(6):1711-7. PubMed ID: 11419819
[TBL] [Abstract][Full Text] [Related]
17. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis.
El-Serag HB; Graham DY; Satia JA; Rabeneck L
Am J Gastroenterol; 2005 Jun; 100(6):1243-50. PubMed ID: 15929752
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of Helicobacter pylori infection in patients with reflux esophagitis. A case-control study].
Carmona-Sánchez R; Navarro-Cano G
Rev Gastroenterol Mex; 2003; 68(1):23-8. PubMed ID: 12940095
[TBL] [Abstract][Full Text] [Related]
19. Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups.
Talley NJ; Weaver AL; Zinsmeister AR
Am J Gastroenterol; 1994 Apr; 89(4):524-8. PubMed ID: 8147354
[TBL] [Abstract][Full Text] [Related]
20. Long-term complications to reflux disease in community practice. A 17-year cohort study of 4706 patients.
Hvid-Jensen F; Pedersen L; Munk EM; Drewes AM; Funch-Jensen P
Scand J Gastroenterol; 2011 Oct; 46(10):1179-86. PubMed ID: 21793632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
